Post-covid functional diseases of gastrointestinal tract-Reference-Cited by-同舟云学术

Post-covid functional diseases of gastrointestinal tract

Published:2024-02-24 Issue:4 Volume: Page:72-76
ISSN:0514-2415
Container-title:Health care of Tajikistan
language:
Short-container-title:jour

Author:

Olimzoda N. H.¹,Avezov S. A.¹,Ishankulova D. M.¹,Khuzhamurotov M. H.¹,Odinaev R. I.¹

Affiliation:

1. State Institution “Institute of Gastroenterology of the Republic of Tajikistan”

Abstract

Aim. To assess the frequency of functional gastrointestinal diseases after COVID-19 and identify factors associated with the post-COVID esophageal syndrome.Materials and methods. The study included data from 72 (31 men and 41 women) patients over the age of 18 who had COVID-19. Patients were divided into two groups: with or without gastroenterological symptoms during acute coronavirus infection.Results and Discussion: After 6 months from the onset of the coronavirus infection, Irritable Bowel Syndrome (IBS) developed in 29% of patients with gastrointestinal symptoms and only in 7% of patients without symptoms in the acute stage of infection. The concurrent development of two digestive system diseases (more often a cross syndrome of Functional Dyspepsia and IBS) was 2.6 times more common in the first group of patients. Statistically significant risk factors for the development of post COVID functional digestive diseases were: diarrhea, abdominal pain, anorexia, anosmia, and agenesis.Conclusion. The presence of gastrointestinal symptoms at the baseline level of COVID-19 was more frequently associated with the development of functional gastrointestinal tract disorders during a six-month follow-up.

Publisher

Healthcare of Tajikistan

Reference13 articles.

1. Mirodzhov G. K., Avezov S. A., Khudzhamurodov M.N. Chastota porazheniya organov pishchevareniya i pecheni pri ostroy vnebolnichnoy pnevmonii [Frequency of lesions of digestive organs and liver in acute out-of-hospital pneumonia]. Problemy gastroenterologii - Problems of gastroenterology, 2022, No. 2, p. 5-10.

2. Sheptulin A.A., Kurbatova A.A. Novye Rimskie kriterii funktsionalnoy dispepsii IV peresmotra [New Rome criteria for functional dyspepsia IV revision]. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii - Russian journal of gastroenterology, hepatology, coloproctology, 2016, No. 26 (4), pp. 124- 128.

3. Austhof E., Bell M.L., Riddle M.S. Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT. Epidemiology and infection, 2022, No. 150, pp. e136.

4. Britton G.J., Chen Liaw A., Cossarini F. SARS‐CoV‐2‐specific IgA and limited inflammatory cytokines are present in the stool of select patients with acute COVID‐19. Scientific Reports, 2021, No. 11, pp. 13308.

5. Chai X., Hu L., Zhang Y., Han W., Lu Z., Ke A. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. BioRxiv, 2020.